PsyBio Completes Reverse Take-Over Transaction Common Shares Expected to Commence Trading on the TSX Venture Exchange Imminently
February 19, 2021 15:17 ET | Source: PsyBio Therapeutics Corp. PsyBio Therapeutics Corp.
Not for distribution to United States newswire services or for release publication,
distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States.
TORONTO, Feb. 19, 2021 (GLOBE NEWSWIRE) PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (the “
Company”), announces that it has completed its previously announced reverse takeover of PsyBio Therapeutics, Inc. (“
PsyBio”), a biotechnology company developing a new class of drugs intended for the treatment of mental health challenges and other disorders (the “
United-states
Ohio
United-kingdom
Canada
Toronto
Ontario
Miami-university
British
Nitin-kaushal
Gerry-goldberg
Noah-davis
Evan-levine
Assumes a Consolidation ratio for the Common Shares of 1.6667:1
In the event that the Qualifying Transaction is completed, the directors of the Company who are not directors of the Resulting Issuer will have a period of 12 months to exercise their Options.
In addition, the Company will also apply to the TSXV to extend the expiry date of the option grants expiring on February 17, 2021 to March 5, 2023.
The Options are expected to represent less than 1% of the issued and outstanding shares of the resulting issuer following the Qualifying Transaction.
In addition, the Supplement will add an additional approval threshold for the Continuance Resolution (as defined in the Circular) asking shareholders to approve, among other things, the reclassification of the Corporation s existing Common Shares as subordinate voting shares (the
United-states
Canada
United-kingdom
Toronto
Ontario
British
Canadian
Gerry-goldberg
Company-common
Psybio-therapeutics-inc
Leo-acquisitions-corp
Capital-pool-company
KWG Resources Inc.: KWG Announces Proposed Private Placement of Flow-Through Units KWG Resources Inc. (CSE: KWG) (CSE: KWG.A) (FSE: KW6)
( KWG or the Company ) is pleased to announce a proposed non-brokered private placement of up to 280,000 flow-through units (each a
Flow-Thorough Unit ) at a price of $1.5001 per Flow-Through Unit for aggregate gross proceeds of up to $420,028 (the
Offering ). Each Flow-Through Unit is comprised of one multiple voting share of the Company (each, a
Multiple Voting Share ) issued on a flow-through basis in accordance with the
Income Tax Act (Canada) (each a
Flow Through Share ) and one multiple voting share purchase warrant (each a
Kazakhstan
Japan
United-states
India
Aroland
Ontario
Canada
South-africa
Indonesia
Toronto
South-korea
Turkey
(1)
Chicago, Illinois (Newsfile Corp. - December 18, 2020) - RCP23, LLC (the Seller ), a private investment holding company controlled by Benjamin Kovler, CEO and Chairman of Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) (the Issuer ), sold 2,500,000 Subordinate Voting Shares of the Issuer (the Transferred Shares ) to a third-party qualified institutional buyer at a purchase price of C$27.50 per share in a private transaction.
Following the sale, Mr. Kovler, together with his joint actors, holds beneficial ownership or control or direction over 183,254 Super Voting Shares, which represent 58.7% of the class, 0 Multiple Voting Shares, and 2,568,016 Subordinate Voting Shares, which represent 1.4% of the class. The interests in the Seller are held by approximately 300 investors. This transaction represents less than 3% of Mr. Kovler s personal holdings in the Issuer. Each Super Voting Share carries 1,000 votes and is convertible into one Multiple Voting Share and each
Chicago
Illinois
United-states
Benjamin-kovler
National-instrument
Illinois-newsfile-corp
Green-thumb-industries-inc
Green-thumb-industries
Voting-shares
Each-super-voting-share
Multiple-voting-share
Investor-relations
vimarsana © 2020. All Rights Reserved.